Inflammatix secures $57M for its breakthrough infectious disease test, pending FDA review, aiming to revolutionize sepsis ...
The UK's chief vet highlights the bTB fight's crucial stage as Defra plans to end badger culling, sparking protests and ...
Terns Pharmaceuticals has announced a $125 million stock offering, following the release of promising Phase I data for TERN-601, their oral candidate aimed at obesity. This significant move positions ...
In phase 3 trials, GSK’s long-acting asthma medication, depemokimab, showed encouraging results, reducing the frequency of asthma attacks in individuals with severe asthma and type 2 inflammation.
In a ground-breaking development, Samphire Neuroscience has introduced NETTLE, a medical-grade wearable designed to alleviate PMS and menstrual pain without drugs or hormones. Co-founded by Emilė ...
Zepp Health Corporation, a leading innovator in smart wearables, has teamed up with wellness app Wild.AI to introduce advanced women’s health features to Amazfit smartwatches. Starting with the ...
Vita Animal Health has introduced an enhanced version of its cardiac health supplement, Omnicardio Plus, specifically designed for cats and dogs. This new formula features astaxanthin, a potent ...
Carestream Dental, a leading provider of digital dental solutions, has secured a substantial $525 million investment through a recapitalization led by General Atlantic Credit’s Atlantic Park fund.
In a recent development, the Scottish Medicines Consortium has approved Tecvayli (teclistamab) for patients with RRMM, making Scotland the first UK nation to authorize this innovative bispecific ...
Adcendo has struck a licensing deal with China-based Multitude for their tissue factor-targeting ADC candidate, possibly valued over $1 billion, adding another instance to the trend of antibody drug ...
Trinity Capital Inc. has provided $50 million in growth capital to LightForce, a company pioneering personalized 3D printed braces. This significant investment is expected to advance orthodontic ...
Christie & Co successfully brokered the acquisition of three Rejuvadent dental practices in East Yorkshire by Jonathan Schonberg of April Holdings Dental Group. The transaction expands Schonberg’s ...